Overview

The Effect of Desloratadine and Levocetirizine on Nasal Obstruction (Study P03609)

Status:
Completed
Trial end date:
2004-05-01
Target enrollment:
Participant gender:
Summary
This was a study to measure the ability of desloratadine and levocetirizine to decrease nasal obstruction in subjects who had study-induced allergic rhinitis. Study participants had allergic rhinitis symptoms induced in a Vienna Challenge Chamber and then received desloratadine or levocetirizine for 8 days. After at least a 10 to 35-day washout period (time when no drug is given), subjects received the opposite treatment for 8 days. Subjects had their total nasal symptom measured.on the 8th day of each treatment period.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Cetirizine
Desloratadine
Levocetirizine
Loratadine